Video

Dr. Masrouha on the Challenges of Surgical Removal of Chordoma Tumors

Karim Masrouha, MD, discusses the challenges of surgically removing chordoma tumors.

Karim Masrouha, MD, assistant professor, Department of Orthopaedic Surgery, NYU Grossman School of Medicine, orthopedic surgeon, director, New York Ponseti Clubfoot Center, NYU Langone Health, discusses the challenges of surgically removing chordoma tumors.

Chordoma tumors are typically slow growing and indolent, so they are often very large at presentation when patients become symptomatic, Masrouha says. Therefore, the tumors are difficult to surgically remove with wide enough margins and without sacrificing some sacral nerve roots, Masrouha explains.

Although surgery for chordoma doesn’t affect ambulation, sensation, or motor function, it can negatively affect bladder, bowel, and sexual function, Masrouha says. Moreover, tumors that are high in the sacrum require most of the sacrum to be resected, which leads to fairly morbid functional outcomes, Masrouha concludes.

Related Videos
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Tiago Biachi, MD, PhD
Dr Girard on De Novo and Acquired Resistance Alterations in HER2-Altered NSCLC
Elias Jabbour, MD
Daniel DeAngelo, MD, PhD
Douglas W. Sborov, MD, MS